Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular FDC Pill AAR vs Altace and Lipitor in Hypertension and Hypercholesterolemia
NCT02791958Phase 2Unknown
- Sponsor
- Ferrer
- Start
- Mar 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of aspirin + atorvastatin + ramipril in hypertension (HTN) and hypercholesterolemia (3 arms), sponsored by Ferrer. Primary endpoints: Difference in adjusted mean 24-h systolic blood pressure (ABPM) at 8 weeks and Difference in LDL cholesterol at 8 weeks. Status: unknown.
02
Drugs
aspirin + atorvastatin + ramipril
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT02791958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02791958.